Cargando…
Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters
BACKGROUND: The tumor suppressor gene p53 (TP53) controls numerous signaling pathways and is frequently mutated in human cancers. Novel p53 isoforms suggest alternative splicing as a regulatory feature of p53 activity. RESULTS: In this study we have analyzed mRNA expression of both wild-type and mut...
Autores principales: | Baumbusch, Lars O, Myhre, Simen, Langerød, Anita, Bergamaschi, Anna, Geisler, Stephanie B, Lønning, Per E, Deppert, Wolfgang, Dornreiter, Irene, Børresen-Dale, Anne-Lise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636663/ https://www.ncbi.nlm.nih.gov/pubmed/17054774 http://dx.doi.org/10.1186/1476-4598-5-47 |
Ejemplares similares
-
Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005) -
The Δ133p53 Isoforms, Tuners of the p53 Pathway
por: Joruiz, Sebastien M., et al.
Publicado: (2020) -
Differential regulation of p53 function by the N-terminal ΔNp53 and Δ113p53 isoforms in zebrafish embryos
por: Davidson, William R, et al.
Publicado: (2010) -
Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997) -
The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
por: Arsic, Nikola, et al.
Publicado: (2015)